Julia Tang, MD
Gastroenterology · Chapel Hill, NCNPI 1194760868
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $404 of the $488 with a category attached, or 82.8%. 8 manufacturers reported payments, led by Johnson & Johnson at 45.1% of the total. 2025 is the largest year on record at $304, more than ten times the $13 reported in 2023. That places this record below the midpoint for gastroenterology clinicians in NC, where the typical reported total is $1,694.
Across 19 payments — averaging $25.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$220
- Ardelyx, Inc.$95
- Sanofi$45
- Takeda Pharmaceuticals U.S.A., Inc.$35
- Mylan Specialty L.p.$28
- Lilly USA, LLC$22
- plus $42 from 2 others
What the payments were for
- Food & beverage$40483%
- Education$8417%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 7 | $220 |
| Ardelyx, Inc. | 4 | $95 |
| Sanofi | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Mylan Specialty L.p. | 1 | $28 |
| Lilly USA, LLC | 1 | $22 |
| Exact Sciences | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
How this compares
$488 in reported general payments places this provider in the 25th percentile of 610 gastroenterology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 12 | $156,733 |
| LinzessLinaclotide | 36 | $30,394 |
| Mesalamine | 22 | $12,410 |
| Lubiprostone | 11 | $3,480 |
| Budesonide DrBudesonide | 28 | $2,865 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 23 | $1,692 |
| Omeprazole | 78 | $1,486 |
| Budesonide EcBudesonide | 12 | $1,428 |
| Lansoprazole | 52 | $1,110 |
| Pantoprazole Sodium | 38 | $862 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 28 | $665 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Chapel Hill
- Paul WatkinsChapel Hill$876K
- Evan DellonChapel Hill$431K
- Alfred BarrittChapel Hill$210K
- Nicholas ShaheenChapel Hill$145K
- Christine HuntChapel Hill$122K
- Hans HerfarthChapel Hill$78K
- Simon GrayChapel Hill$48K
- Jasmine BarrowChapel Hill$22K
- Stephen DealCharlotte$945K
- Fred FowlerCharlotte$932K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.